Welcome to Novo Nordisk in the United States
  • Improving Patient's Lives

    For nearly a century, Novo Nordisk has focused on diabetes care and areas of unmet needs, keeping the patient at the center of everything we do.

Our Executive Team

At Novo Nordisk our leadership represents a broad, diverse array of life experiences with one very important commonality: a dedication to patient needs.

Doug Langa, Executive Vice President, North America Operations and President of Novo Nordisk Inc.

Doug Langa
Executive Vice President
North America Operations and President of Novo Nordisk Inc.

Steve Albers, Corporate Vice President, Market Access of Novo Nordisk Inc.

Steve Albers
Corporate Vice President
Market Access and Public Affairs

Pia D' Urbano, Corporate Vice President, Biopharmaceuticals of Novo Nordisk Inc.

Pia D' Urbano
Senior Vice President

Jill Fallows Macaluso, Corporate Vice President, Chief Compliance Officer of Novo Nordisk Inc.

Jill Fallows Macaluso
Corporate Vice President
Chief Compliance Officer

Marc Fishman, Interim Corporate Vice President, Legal, Vice President, Associate General Counsel

Anna Frable
Vice President

Jamie Haney, Corporate Vice President, Legal & General Counsel

Jamie Haney
Corporate Vice President
Legal & General Counsel

Brian Hilberdink, Senior Vice President, Commercial Diabetes

Brian Hilberdink
Senior Vice President

Blandine Lacroix, Corporate Vice President CVP Obesity

Blandine Lacroix
Corporate Vice President
BioPharm & Strategy

Maryellen McQuade, Corporate Vice President, Human Resources of Novo Nordisk Inc.

Maryellen McQuade
Corporate Vice President
Human Resources

Ulrich Otte, Senior Vice President, Finance & Operations of Novo Nordisk Inc.

Ulrich Otte
Senior Vice President
Finance & Operations

Anne Phillips, MD, Senior Vice President, Clinical Medical and Regulatory Affairs of Novo Nordisk Inc.

Anne Phillips, MD
Senior Vice President
Clinical Medical and Regulatory Affairs

Richard Sperry
Vice President, Executive Office
and Chief of Staff